National International Holding Company K.S.C.P. (KWSE:NIH)
Kuwait
· Delayed Price · Currency is KWD · Price in KWF 0.176
+0.006 (3.53%)
At close: Apr 28, 2026
KWSE:NIH Income Statement
Financials in millions KWD. Fiscal year is January - December.
Millions KWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Operating Revenue | 4.06 | 4.04 | 4.46 | 4.32 | 3.34 | Upgrade
|
| Other Revenue | 2.52 | 4.13 | 3.49 | 2.52 | 2.51 | Upgrade
|
| Revenue | 6.58 | 8.18 | 7.95 | 6.84 | 5.85 | Upgrade
|
| Revenue Growth (YoY) | -19.50% | 2.82% | 16.25% | 16.92% | 3620.84% | Upgrade
|
| Cost of Revenue | 2.93 | 2.94 | 3.39 | 3.39 | 2.39 | Upgrade
|
| Gross Profit | 3.65 | 5.23 | 4.56 | 3.45 | 3.46 | Upgrade
|
| Selling, General & Admin | 1.76 | 1.6 | 1.73 | 1.57 | 1.53 | Upgrade
|
| Other Operating Expenses | 0.03 | 0.03 | 0.03 | 0 | -0.07 | Upgrade
|
| Operating Expenses | 1.83 | 1.63 | 1.75 | 1.58 | 1.46 | Upgrade
|
| Operating Income | 1.82 | 3.61 | 2.8 | 1.87 | 1.99 | Upgrade
|
| Interest Expense | -0.22 | -0.22 | -0.24 | -0.16 | -0.14 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.01 | -0 | -0 | - | -0 | Upgrade
|
| EBT Excluding Unusual Items | 1.59 | 3.38 | 2.56 | 1.71 | 1.85 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | -1.52 | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | - | -0.01 | -0.05 | Upgrade
|
| Asset Writedown | 0.31 | - | - | - | -0 | Upgrade
|
| Pretax Income | 1.9 | 1.87 | 2.56 | 1.7 | 1.8 | Upgrade
|
| Income Tax Expense | 0.01 | 0.01 | 0.01 | 0 | 0 | Upgrade
|
| Earnings From Continuing Operations | 1.89 | 1.86 | 2.55 | 1.7 | 1.8 | Upgrade
|
| Minority Interest in Earnings | 0.02 | -0.22 | -0.28 | 0.03 | -0 | Upgrade
|
| Net Income | 1.91 | 1.64 | 2.28 | 1.72 | 1.79 | Upgrade
|
| Net Income to Common | 1.91 | 1.64 | 2.28 | 1.72 | 1.79 | Upgrade
|
| Net Income Growth | 16.21% | -28.04% | 32.36% | -4.03% | - | Upgrade
|
| Shares Outstanding (Basic) | 246 | 243 | 242 | 231 | 224 | Upgrade
|
| Shares Outstanding (Diluted) | 246 | 243 | 242 | 231 | 224 | Upgrade
|
| Shares Change (YoY) | 1.03% | 0.29% | 5.02% | 2.86% | -2.25% | Upgrade
|
| EPS (Basic) | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | Upgrade
|
| EPS (Diluted) | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | Upgrade
|
| EPS Growth | 15.02% | -28.25% | 26.03% | -6.69% | - | Upgrade
|
| Free Cash Flow | 1.86 | -1.19 | -0.4 | -0.85 | 0.91 | Upgrade
|
| Free Cash Flow Per Share | 0.01 | -0.01 | -0.00 | -0.00 | 0.00 | Upgrade
|
| Dividend Per Share | 0.002 | - | 0.006 | 0.005 | 0.005 | Upgrade
|
| Dividend Growth | - | - | 21.28% | 2.17% | - | Upgrade
|
| Gross Margin | 55.45% | 64.01% | 57.31% | 50.37% | 59.08% | Upgrade
|
| Operating Margin | 27.64% | 44.10% | 35.25% | 27.32% | 34.10% | Upgrade
|
| Profit Margin | 28.95% | 20.06% | 28.66% | 25.17% | 30.66% | Upgrade
|
| Free Cash Flow Margin | 28.28% | -14.50% | -5.06% | -12.47% | 15.49% | Upgrade
|
| EBITDA | 1.95 | 3.78 | 2.89 | 2.05 | 2.13 | Upgrade
|
| EBITDA Margin | 29.70% | 46.29% | 36.41% | 29.97% | 36.43% | Upgrade
|
| D&A For EBITDA | 0.14 | 0.18 | 0.09 | 0.18 | 0.14 | Upgrade
|
| EBIT | 1.82 | 3.61 | 2.8 | 1.87 | 1.99 | Upgrade
|
| EBIT Margin | 27.64% | 44.10% | 35.25% | 27.32% | 34.10% | Upgrade
|
| Effective Tax Rate | 0.34% | 0.30% | 0.24% | 0.00% | 0.15% | Upgrade
|
| Revenue as Reported | 6.89 | 8.18 | 7.95 | 6.83 | 5.88 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.